Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Memantine, sold under the brand name Namenda among others, is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. It is taken by mouth.
History, Community, Culture & Applications
Explore the main themes, entities and connections around Memantine. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
disease receptor nmda treatment affinity effects alzheimer's drug amantadine however receptors parkinson's antagonist use used may include review ic50 nm
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Memantine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Memantine | 3D model (JSmol) | as HCl: Interactive image | 1.00 | infobox |
| Memantine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Memantine | ATC code | N06DX01 (WHO) | 1.00 | infobox |
| Memantine | Bioavailability | 100% | 1.00 | infobox |
| Memantine | CAS Number | 19982-08-2 Y | 1.00 | infobox |
| Memantine | CAS Number | as HCl: 41100-52-1 | 1.00 | infobox |
| Memantine | ChEBI | CHEBI:64312 | 1.00 | infobox |
| Memantine | ChEBI | as HCl: CHEBI:64323 | 1.00 | infobox |
| Memantine | ChEMBL | ChEMBL807 Y | 1.00 | infobox |
| Memantine | ChEMBL | as HCl: ChEMBL1699 | 1.00 | infobox |
| Memantine | ChemSpider | 3914 Y | 1.00 | infobox |
| Memantine | ChemSpider | as HCl: 157849 | 1.00 | infobox |
| Memantine | CompTox Dashboard (EPA) | DTXSID5045174 | 1.00 | infobox |
| Memantine | Drug class | NMDA receptor antagonist | 1.00 | infobox |
| Memantine | DrugBank | DB01043 Y | 1.00 | infobox |
| Memantine | DrugBank | as HCl: DBSALT000456 | 1.00 | infobox |
| Memantine | ECHA InfoCard | 100.217.937 | 1.00 | infobox |
| Memantine | Elimination half-life | 60–80 hours | 1.00 | infobox |
| Memantine | Excretion | Urine (57–82% unchanged) | 1.00 | infobox |
| Memantine | Formula | C12H21N | 1.00 | infobox |
| Memantine | IUPHAR/BPS | 4253 | 1.00 | infobox |
| Memantine | KEGG | D08174 Y | 1.00 | infobox |
| Memantine | KEGG | as HCl: D04905 | 1.00 | infobox |
| Memantine | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Memantine | Legal status | BR: Class C1 (Other controlled substances) | 1.00 | infobox |
| Memantine | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Memantine | Legal status | US: ℞-only | 1.00 | infobox |
| Memantine | Legal status | EU: Rx-only | 1.00 | infobox |
| Memantine | License data | US DailyMed: Memantine | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.